Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Fund and Insider Trading News: Waratah Capital Advisors, Dalton Investments, AQR Capital Management, CARN Capital, BrightSphere Investment Group Inc (BSIG), Dave & Buster’s Entertainment Inc (PLAY), and More

Nordic Names Take Home European Awards (Hedge Nordic)
Stockholm (HedgeNordic) – Three Nordic hedge funds have been distinguished at this year’s Hedge Funds Review European Performance Awards. Accendo Capital, CARN Long Short and Othania Etisk Formuevækst featured among the winners at this year’s edition the event organized by Hedge Funds Review. This year is the 20th anniversary of the Hedge Funds Review European Performance Awards, with the winners announced online last week rather than a usual awards dinner in London. The selection process of the winners at the Hedge Funds Review European Performance Awards relies on more than just numbers. Expert judging panels review the risk and return characteristics of each fund to select the winners in each award category, considering qualitative factors and drawing on the experience and knowledge of each judge. The awards seek to reward genuine performance, quality and skill.

Monday 6/29 Insider Buying Report: BSIG, EPZM (
At Brightsphere Investment Group, a filing with the SEC revealed that on Wednesday, John Paulson purchased 647,263 shares of BSIG, for a cost of $9.79 each, for a total investment of $6.34M. Paulson was up about 26.6% on the buy at the high point of today’s trading session, with BSIG trading as high as $12.39 at last check today. Brightsphere Investment Group is trading up about 4.1% on the day Monday. And on Friday, Director David M. Mott bought $994,165 worth of Epizyme, buying 62,019 shares at a cost of $16.03 a piece. Epizyme is trading up about 10.3% on the day Monday.

The SVP, RE & Dev of Dave & Busters Entertainment (NASDAQ: PLAY) is Selling Shares (Analyst Ratings)
Yesterday, the SVP, RE & Dev of Dave & Busters Entertainment (PLAY), John Mulleady, sold shares of PLAY for $163.9K. In addition to John Mulleady, 3 other PLAY executives reported Sell trades in the last month. The company has a one-year high of $48.80 and a one-year low of $4.61. PLAY’s market cap is $656 million and the company has a P/E ratio of 41.70. Currently, Dave & Busters Entertainment has an average volume of 15.18M.

Notable Insider Buys: Continental Resources, Fox, Groupon And More (Benzinga)
Insiders continued to add shares despite overall market volatility and economic uncertainty. The following are some of the most noteworthy insider purchases reported in the past week. Continental Resources, Inc. (CLR) says its founder and executive chair Harold Hamm picked up more than 3.43 million shares of this Oklahoma City-based company for $15.29 to $17.48 each. That totaled over $57.11 million and brought his stake to almost 5.18 million shares. CEO Pablo Legorreta and other executives and directors at Royalty Pharma plc (RPRX) bought into the initial public offering. The more than 1.67 million shares were priced at $28 each, and that totaled around $46.82 million. A 10% owner also purchased 3 million shares.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
This is a FREE report from Insider Monkey. Credit Card is NOT required.